Showing results (41-50 of 84) with videos related to

Sort By:
Pageof 9
Cancers|May 14, 2022
Azacitidine vs. Decitabine in Unfit Newly Diagnosed Acute Myeloid Leukemia Patients: Results from the PETHEMA RegistryJorge Labrador, David Martínez-Cuadrón, Adolfo de la Fuente, et al.
Cancers|February 13, 2025
Ketone Bodies Are Potential Prognostic Biomarkers in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Results from the R2-GDP-GOTEL TrialSara Fernández-Castillejo, Joan Badia, Luís de la Cruz-Merino, et al.
Blood Advances|October 14, 2022
Integrated flow cytometry and sequencing to reconstruct evolutionary patterns from dysplasia to acute myeloid leukemiaCatia Simoes, Maria-Carmen Chillon, David Martínez-Cuadrón, et al.
Cancers|June 2, 2021
The Mutational Landscape of Acute Myeloid Leukaemia Predicts Responses and Outcomes in Elderly Patients from the PETHEMA-FLUGAZA Phase 3 Clinical TrialRosa Ayala, Inmaculada Rapado, Esther Onecha, et al.
Cancers|December 11, 2022
Impact of FLT3-ITD Mutation Status and Its Ratio in a Cohort of 2901 Patients Undergoing Upfront Intensive Chemotherapy: A PETHEMA Registry StudyRosa Ayala, Gonzalo Carreño-Tarragona, Eva Barragán, et al.
Leukemia Research|April 3, 2020
Performance of prognostic scoring systems in elderly patients with acute myeloid leukaemia on intensive chemotherapy: A PETHEMA registry studyCarlos Rodríguez-Medina, David Martínez-Cuadrón, Isabel Cano, et al.
Haematologica|February 27, 2025
Prognostic relevance of variant allelic frequency for treatment outcomes in patients with acute myeloid leukemia: a study by the Spanish PETHEMA registryRafael Colmenares, Noemi Alvarez, Eva Barragan, et al.
Cancer|February 24, 2021
A phase 3 trial of azacitidine versus a semi-intensive fludarabine and cytarabine schedule in older patients with untreated acute myeloid leukemiaSusana Vives, David Martínez-Cuadrón, Juan Bergua Burgues, et al.
Annals of Hematology|December 19, 2023
Incidence, risk factors, and outcomes of second neoplasms in patients with acute promyelocytic leukemia: the PETHEMA-PALG experienceMarta Sobas, Wanda Knopinska-Posluszny, Beata Piątkowska-Jakubas, et al.
Leukemia|December 14, 2018
Flow cytometry for fast screening and automated risk assessment in systemic light-chain amyloidosisNoemi Puig, Bruno Paiva, Marta Lasa, et al.
Pageof 9